Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$11.13
+1.18%
Mkt Cap $261.88M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+79.7%
Consensus $20.00 vs current $11.13
NASDAQ·Healthcare·Biotechnology
$11.13
+1.18%
Mkt Cap $261.88M
No recent rating data.
Price Target (6 analysts)
$20.00
Range $20.00 – $20.00
+79.7%
Consensus $20.00 vs current $11.13